Adma Biologics ADMA
NASDAQ ADMA
$9.96 -0.16 (-1.58%)
At close: Sep 29, 2026 · 4:00 PM EDT

Adma Biologics (ADMA) Short term Debt (2025 - 2026)

Updated

Adma Biologics' Short term Debt was $3.75 million in Q2 2026, up 14.3% from the prior quarter.

Analysis

Adma Biologics (ADMA) Short term Debt (2025 - 2026) Analysis & Trends

At the end of FY2025, Short term Debt at Adma Biologics came in at $2.81 million.

  • Per Business Quant data, ADMA's Short term Debt in the three quarters before Q2 2026 was $3.28 million (Q1 2026), $2.81 million (Q4 2025) and $2.34 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn
10 Adma Biologics 2.28 Bn 1.86 Bn 86.28 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 3.75 Mn
Mar 31, 2026 3.28 Mn
Dec 31, 2025 2.81 Mn
Sep 30, 2025 2.34 Mn
API Access

Adma Biologics Short term Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt&ticker=ADMA&period=max&api_key=YOUR_API_KEY